Publication | Closed Access

Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer

Oncogenic AgentMedicineCatabolic EnzymesDeoxycitidine KinaseCancer BiologyPrimary Ovarian CancerTumor SuppressorRadiation OncologyOncologyCell BiologyEndocrine-related CancerOvarian Cancer